tility of resistance index (RI) measured with renal doppler ultrasonography to elucidate induction therapy of Tolvapta
Not Applicable
Recruiting
- Conditions
- liver cirrhosis with ascites
- Registration Number
- JPRN-UMIN000027765
- Lead Sponsor
- ational Hospital Organization Tokyo Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
(1) active gastrointestinal bleeding, (2) overt hepatic encephalopathy, (3) spontaneous bacterial peritonitis, (4) heart failure and stage 4 chronic kidney disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical benefits estimated 3 months later.
- Secondary Outcome Measures
Name Time Method